Print

Featured Event...



ChinaBio® Partnering Forum 2012

May 23-24, 2012 | Suzhou, China

 Register now and save up to $ 200!

ChinaBio® LLC and EBD Group will host their fourth ChinaBio® Partnering Forum in China to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. ChinaBio® Partnering Forum is the largest partnering conference in China, drawing more than 700 delegates and 400 companies from all over the world in 2012. Companies and researchers with novel technologies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the global financing network are welcome to apply to present. With over one-third of the attendees being C-level decision makers, ChinaBio® Partnering Forum is the event to get partnerships started in China.

To find out more about presenting to international pharma, click here!

>> See  http://www.cbpf2012.com/ for more information.


 New!  Top Stories


WuXi PharmaTech and ShangPharma Are M&A Targets: Bloomberg | Feb 3, 2012 

China Excitement at J.P. Morgan Healthcare Conference | Jan 15, 2012 

China Announces Major Program for Biotechnology 2010-2020 | Jan 6, 2012 

Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China | Dec 6, 2011 

China's 12th Five-year Plan for Medical Technology | Dec 2, 2011

>> See all top stories...


Recent Articles

First event iApply to present now! Deadline: April 30

Recent Articles

  Changchun BCHT Biotech Acquires Flu Vaccine Technology (in: Deals & Financings)
  Shanghai Pharma to Spend $80 Million on North China Expansion (in: Deals & Financings)
  Takeda Sets Up China Division to Supervise Clinical Trials (in: News & Analysis)
  Once Again, Fosun Pharma Plans Hong Kong IPO (in: Deals & Financings)
  Shanghai Biochip Signs MOU with GeneNews of Canada (in: Deals & Financings)
  Nanjing Pharma’s Weak Financials Spark Takeover Talk (in: Deals & Financings)
  Shanghai Pharma Acquires Second API Maker this Year (in: Deals & Financings)
  The Week in Review: Are WuXi PharmaTech and ShangPharma Takeover Targets? (in: Week in Review)
  Steve Yang: AstraZeneca in China Wants to Transform Pharma R&D Models (in: Featured Companies)
  Cardinal Health Plans $90 Million in China Acquisitions (in: Deals & Financings)